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Apoptosis and mitochondrial membrane potential changes of T 
lymphocytes from children with Down’s syndrome  
 
INTRODUCTION 
Down's syndrome (DS, trisomy 21) is the most 
common chromosomal abnormality in humans that 
occurs in 1 out of every 800-1000 births. Many 
characteristics are commonly seen in DS, including 
intellectual impairment, heart defects, hypotonia, 
hyperuricemia, and development of Alzheimer 
disease1. DS patients also present a high risk of 
developing alterations of the immune system with 
lack of cell mediated immunty, which are similar to 
aged people, including increase susceptibility to 
bacterial and viral infection, hematologic 
malignancies and autoimmune disease, suggesting 
that immunodeficiency is an integral part of DS. 
This contributes significantly to the observed 
increase in the morbidity and mortality1-3.  
Apoptosis is a genetically controlled process in 
which the cell actively participates in its own 
destruction in response to various types of stress. 
Apoptosis plays a key role in the homeostatic 
regulation of the hematopoietic system4. Apoptosis 
plays an essential role in T cell development, the 
shaping of the immune repertoire, and in the 
ordinate initiation and final resolution of the 
immune responses to exogenous dangerous signals5. 
The dysregulation of apoptosis in the immune 
system results in immunodeficiency and 
autoimmunity6. Mitochondria play a pivotal role in 
the regulation of apoptosis. An early and key event 
during apoptosis is that the mitochondrial outer 
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membrane becomes permeable, leading to release 
of apoptogenic factors into the cytosol7. Thus, 
evaluation of mitochondrial membrane potential 
(∆Ψm) is of critical importance for the assessment 
of apoptosis8.  
Changes in mitochondrial functionality and 
increased apoptosis have been described in neurons 
of patients affected by DS9. These alterations are 
supposed to be responsible for the precocious onset 
of Alzheimer disease in patients affected by DS. As 
regards the peripheral blood cells, Roat et al10 found 
alterations in the distribution of several lymphocyte 
subpopulations and investigated the mitochondrial 
damage and apoptosis in peripheral blood 
mononuclear cells from DS children after in vitro 
treatment with apoptogenic molecules. However, to 
the best of our knowledge, no one investigated the 
tendency to spontaneous apoptosis in peripheral T 
cells from DS patients. Therefore, our aim was to 
evaluate the tendency to apoptosis and 
mitochondrial membrane potential changes in T 
lymphocytes from DS children both in the presence 
and in the absence of acute infection. 
 
METHODS 
This case control study included 30 children with 
DS (trisomy 21, nondisjunction type) recruited from 
Assiut University Children's Hospital from January 
to December 2008. Fifteen of them had no acute 
infection; they were 11 males and 4 females with a 
mean age of 14 ± 6.04 months. Another fifteen 
were studied during acute infections; 10 with 
bronchopneumonia, 3 with acute gastroenteritis, 1 
with both of them and 1 with acute otitis media. 
They were 9 males and 6 females with a mean age 
of 10 ± 8.94 months. Thirty age and sex matched 
children with normal mentality and without any 
apparent dysmorphic features were studied as 
controls. Of these controls fifteen had no evidence 
of acute infection; they were 10 males and 5 
females with a mean age of 14 ± 7.39 months. The 
other fifteen had acute infections during the study: 
9 had bronchopneumonia, 3 had acute 
gastroenteritis, 2 had both of them and 1 had acute 
gastroenteritis and acute otitis media.  They were 10 
males and 5 females and their mean age was 12.29 
± 5.59 months. Acute infection was confirmed by 
clinical examination and the presence of 
leukocytosis, elevated band counts (increased 
immature white blood cells) and/or elevated ESR. 
Children with congenital malformations e.g. 
congenital heart disease or positive coombs' test 
were excluded from this study. After the approval 
of the ethical committee of Faculty of Medicine- 
Assiut University, an informed written consent was 
obtained from the parents or care givers. Clinical 
history, examination and complete blood picture 
were done for all children included in this study.  
To investigate whether peripheral T cells from 
the patients undergo spontaneous apoptosis, the 
proportion of cells that underwent apoptosis was 
measured by flow cytometry (FCM) using annexin 
V-FITC and propidium iodide (PI) with gating on T 
cells by staining with CyQ-CD3 monoclonal 
antibodies  (IQ product, Groningen, The 
Netherlands). The ∆Ψm is assessed by the retention 
of Rhodamine 123 (Rh123), a specific fluorescent 
cationic dye that is readily sequestered by active 
mitochondria, depending on their transmembrane 
potential11. Hundred µl of cell suspension were 
incubated in two tubes with 10µl of anti-CD3 and 
with 10µl of Annexin V in the first tube only for 20 
min at 4oC protected from light. For the negative 
control isotypic matched mouse IgG antibodies 
were used in a third tube. The cells were washed 
and re-suspended in 100µl PBS. The mitochondria 
were stained by adding to the cell suspension a 
stock solution of Rh123 (10 mM in ethanol, kept in 
the dark, 4ºC) to a final concentration of 1 µM. PI is 
added to discard non-viable cells in the two tubes 
and analyzed by FCM. 
 
FCM analysis 
The flow cytometer (FACSCaliber; Becton 
Dickinson, San Jose, CA) was calibrated using 
CaliBRITTE beads (Becton Dickinson) for three-
color flow cytometer setup. Data acquisition and 
analysis was performed using Cell Quest software 
(Becton Dickinson). The minimum numbers of cells 
required for analysis were 10,000. The lymphocyte 
gate (region 1) was determined manually on the 
basis of forward and side angle light scatter (FSC & 
SSC respectively). Cells were expressed on a 
scatter diagram combining SSC with CD3-CyQ 
fluorescence and a region (region 2) was drawn 
around positive population. The marker for 
determining positive and negative cells was set 
according to the negative control. To select viable 
cells within R2, region (R3) was drawn satisfying 
PI negative. 
To determine the ∆Ψm the fluorescence of 
retained Rh123 was assessed on a histogram of 
FL1-fluorescence and the geometric mean 
fluorescence intensity (GMFI) was recorded (Fig1). 
Another dot plot of Annexin V-FITC versus PI 
gated on R2 was done to assess the percentage of 
potentially apoptotic T cells (Fig 2). Quadrant 
cursors were set according to the negative controls. 
For positive control in this work we used the PI 
positive cells to assess the ∆Ψm in dead cells. 
T cell apoptosis in Down's syndrome 
 37
Statistical analysis: 
Analysis was done using SPSS (version 16). The 
numerical data were represented as mean ± SD. 
Student's t test was used for comparison. The 
difference was considered significant if probability 
(p) values were less than 0.05.  
 
RESULTS 
The details of demographic, clinical and laboratory 
data of all children are listed in table 1. The present 
study revealed that in the absence of acute infection 
there is no significant difference in the percentage 
of CD3+ cells in the peripheral circulation of DS 
children when compared to those of the controls. In 
addition, there was no significant difference in the 
proportion of potentially apoptotic T lymphocytes 
in the peripheral circulation of DS children when 
compared to those of the controls. As regard 
mitochondrial membrane potential (∆Ψm), there 
was a significant decrease in the retention of Rh123 
in DS children when compared to the controls 
(Table 2).  
In DS children all the previous parameters were 
also compared in the presence, versus in the 
absence of acute infection. Both the percentage of 
CD3+ cells and the proportion of potentially 
apoptotic T lymphocytes in the peripheral 
circulation of DS children were significantly higher 
in the presence of acute infection. There was no 
significant difference in ∆Ψm in DS children in the 
presence or absence of acute infection (Table 2).  
All these parameters were compared between DS 
children and the control children in the presence of 
the acute infection. There was only a significant 
decrease in the retention of Rh123 in DS children 
(Table 2).  
All studied variables showed no significant 
correlation with the demographic data of the 




Table 1. Some demographic, clinical and laboratory data of DS patients and controls. 
Down syndrome (30) Controls (30) Demographic, clinical  
and laboratory data Without infection (15) 
With infection 
(15) 




Age (months)  14.23 ± 6.04 10.13 ± 8.94 14.88 ± 7.39 12.29 ± 5.59 
Sex (No. %)     
Male 11 (73.3%) 9 (60.0%) 10 (66.7%) 10 (66.7%) 
Female 4 (26.7%) 6 (40.0%) 5 (33.3%) 5 (33.3%) 
Weight (kgm) (means+/- S.D) 6.83 ± 4.36 5.20 ± 1.94 9.71 ± 3.41 8.77 ± 2.90 
Hb (g/dL) (means+/- S.D) 11.30 ± 1.65 9.79 ± 1.48 11.00 ± 1.39 9.23 ± 2.95 
WBC(×10³/ul) (means+/-S.D) 9.57 ± 3.05 10.67 ± 4.12 9.63 ± 3.01 15.30 ± 8.07 
Quantitative variables are expressed as mean ± standard deviation. 
No = number; Hb = hemoglobin; WBC = white blood cells. 
 
Table 2.  CD3+ %, proportion of potentially apoptotic T lymphocytes and GMFI of Rh123 
(∆Ψm) among DS children and controls. 
 CD3+  
(%) 
Potentially apoptotic  
T lymphocytes (%) 
GMFI of Rh123  
(∆Ψm) 
DS without infection 73.16 ± 4.99 4.39 ± 1.09 6.75 ± 2.97 
DS with infection 82.77 ± 9.82 35.59 ± 11.01 5.22 ± 2.52 
Controls without infection 70.44± 5.30 4.28 ± 1.24 11.40 ± 4.38 
Controls with infection 84.01 ± 10.44 35.47 ± 24.53 11.02 ± 3.80 
P value            A 0.235 0.854 0.008* 
                         B 0.006* 0.000* 0.148 
                         C 0.794 0.990 0.000* 
Quantitative variables are expressed as mean ± standard deviation. 
DS = Down's syndrome; GMFI = geometric mean fluorescence intensity; Rh123 = Rhodamine 123; ∆Ψm = 
mitochondria membrane potential; * = statistically significant result. 
A= p-values when DS without infection group compared with controls without infection group.  
B= p-values when DS without infection group compared with DS with infection group. 
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Figure 1. (a) A scatter diagram combining SSC with CD3-CyQ fluorescence and a region (R2) is 
drawn around positive population for CD3 (T lymphocytes). (b) Region (R3) is drawn satisfying 
PI negative population to select the viable cells. (c) A histogram showing Rh 123-fluorescence 




(a)  (b) 
 
Figure 2. Representative of flow cytometric data revealed that T cells from a healthy control were 
Annexin V and PI negative (a), where as a proportion of T cells from a patient were Annexin V 
positive and PI negative (apoptotic cells) (b). 
 
DISCUSSION 
The immune function in individuals with DS has 
been shown to be defective, especially regarding T 
cell compartment9. The investigation of lymphocyte 
population in peripheral blood has afforded insights 
towards understanding and assessing possible 
immune deficiencies, malignancies, and 
autoimmune diseases2. The present study revealed 
that there was no significant difference of the 
percentage of CD3+ T lymphocyte in the peripheral 
blood from DS children and the control children in 
the absence of acute infection. The percentage of 
CD3+ T lymphocyte increased significantly in DS 
children in the presence of acute infection, but 
remained comparable to those of control children in 
the presence of acute infection. The data of the 
present study are different from those observed by 
Cuadrado and Barrena11, who found that 
quantitative studies of peripheral T lymphocytes in 
DS children revealed a reduction, often quite small 
in the percentage. However, they are in agreement 
with other authors who concluded that the number 
of T lymphocytes both in secondary lymphoid 
organs and in circulation is kept under strict 
control12, so that the CD3+ number is 
maintained13,14.  
T cell apoptosis in Down's syndrome 
 39
As the immunodeficiency is an integral part of 
DS that makes a significant contribution to 
increased morbidity and mortality, so it remains 
questionable whether normal of T- lymphocyte 
counts in children with DS reflects populations with 
normal phenotype and function3. Many authors 
supported the concept that there is an abnormality 
in circulating T lymphocyte subset in children with 
DS and there is abnormal release of immature T 
cells in peripheral blood of DS subjects2,3,11. A 
decreased proportion of mature thymocyte and 
inefficient release of mature T cell in the periphery 
provide a mechanism of impaired cellular responses 
of individuals with DS11. So the function of T cells 
not their number- is the main mechanism 
responsible for the impairment of the immune 
system in DS children and may further add to the 
known fact that cellular immunity is more severely 
affected than humoral immunity in these children15.   
Apoptosis is the mechanism by which the body 
removes both the ineffective and the potentially 
damaging immature cells16,17. The measurement of 
apoptotic activity may greatly enhance possibilities 
for staging the disease18. Flow cytometry- based 
Fluorescence labeling Annexin V has become one 
of the mostly used methods of detecting apoptosis. 
It provides a simple, rapid, sensitive and immediate 
detection method and offers the possibility of 
detecting early phases of apoptosis18,19. The current 
study, revealed that T lymphocytes in peripheral 
blood from DS patients and healthy controls have a 
similar tendency to undergo apoptosis. This is in 
agreement with Roat et al10 who found that 
although different types of cells from DS patients 
have an increased susceptibility to cell death; 
peripheral mononuclear cells do not display an 
increased tendency to undergo apoptosis. However, 
a recent study15 observed increase tendency to 
apoptosis in peripheral T lymphocytes in DS 
children without the exclusion of infection which 
might be the cause of this increase. On the other 
hand, autoimmunity can result from a decreased 
apoptosis of potentially auto reactive T 
lymphocytes and increased resistance to variety of 
apoptogenic stimuli often characterizes tumor 
cells20.  
The tendency to apoptosis of T lymphocytes in 
DS children in the current study,  increased 
significantly in the presence of acute infection. This 
finding can be explained by the fact that apoptosis 
can be triggered by a huge variety of stimuli (e.g. 
toxins, cytokines) via intrinsic and extrinsic 
pathways17,21. Therefore it is not surprising that 
apoptosis is also a response that is found during the 
engagement of the human body with invading 
microbial agents (viral or bacterial) 22,23,24. So in the 
current study we can suggest that this phenomenon 
occurs normally in DS children, evidenced by that 
there was no significant difference of apoptosis of 
peripheral T lymphocytes in both DS and normal 
children in the presence of acute infection. This is 
in agreement with Cochii et al25 who reported that 
in DS children, the immune cellular status is similar 
to normal population. 
Regarding mitochondria, they are essential to 
multi cellular life; without them, a cell ceases to 
respire aerobically and quickly dies, a fact exploited 
by some apoptotic pathways16. The mitochondrial 
membrane impermeability is necessary for 
maintaining the proton gradient which is required 
for oxidative phosphorylation. An early and key 
event during apoptosis, that the mitochondrial 
membrane becomes permeable, leading to release 
of apoptogenic factors into the cytosol. 
Mitochondrial membrane permeability to small ions 
and water causing transmembrane potentiall7 (∆Ψm) 
represent a sensitive parameter of the effectiveness 
of the mitochondrial bio-energic function26.  Several 
cationic dyes distribute electrophoretically into the 
mitochondrial matrix in response to the electric 
potential across the inner mitochondrial membrane. 
These dyes have been extensively employed to 
measure the mitochondrial electric potential 
(∆Ψm)27. In the current study, Rh-123 were used for 
measuring ∆Ψm. The use of Rh-123 for measuring 
∆Ψm is of great interest; it is a sensitive and 
reliable probe of membrane potential in isolated 
mitochondria because the method is simple and 
direct and can be employed using a standard 
fluorometer26.  The present study revealed that cells 
from DS patients show a significant loss of ∆Ψm 
than the control group either in the presence or in 
the absence of acute infection. This finding is 
consistent with previous reports10,28. Thus, since DS 
cells with altered mitochondrial function do not 
undergo apoptosis, it hypothesized that DS patients 
tend to maintain damaged cells, or that they have a 
higher capacity to repair functional damages. It 
remains to be established if and how this 
phenomenon can be linked to development of 
autoimmunity or neoplastic disorders in DS 
individuals10. 
 In conclusion: The function not the number of 
T cells is responsible for the impairment of the 
immune system in DS children. T lymphocytes in 
peripheral blood from DS patients do not display an 
increased tendency to undergo apoptosis and show 
a significant loss of ∆Ψm than the control group. 
Further studies on a wider scale may be needed to 
assess the T lymphocyte function and other 
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